REMAD 02 The goal of this study is to evaluate how safe and effective the new drug…Kimberley Halsall9 June 2022
APOLLOE4 The goal of this study is to evaluate how safe and effective the new drug…Kimberley Halsall21 March 2022
Together The goal of this study is to evaluate the safety and potential effectiveness of the…Kimberley Halsall15 March 2022
Hercules The goal of this research is to find out how safe and potentially effective the…Kimberley Halsall14 March 2022
TA-8995-AD-1 New Amsterdam Pharma The goal of this research is to find out how safe and potentially effective the new drug obicetrapib is for…Kimberley Halsall6 January 2022
Chronicle An interventional, open-label, fixed-dose and multiple administration study to evaluate long-term treatment with Eptinezumab in…Kimberley Halsall1 December 2021
Autonomy A phase II, double-blind, randomized, placebo-controlled study, parallel-group, multicenter research on the safety and effectiveness…Kimberley Halsall11 June 2021
Alector AD A phase II, multicentre, double-blind, randomized, placebo-controlled study of the safety and efficacy of the…Robin Veerman17 March 2021
Open Road An open-label, multicenter, follow-up study to evaluate the safety and tolerability of long-term administration of…Robin Veerman16 March 2021
GEMINI-II A phase III randomized, double-blind study comparing an existing treatment (teriflunomide) with a new one…Robin Veerman16 March 2021